The 2018 Farm Bill and the Legality of CBD in the United States

This new year holds the promise of significant changes in the landscape of the hemp industry in the United States. Monumental events of 2018 set the stage for regulations to change and a burgeoning CBD industry to flourish. The 2018 Farm Bill was passed on December 20, 2018, and initiated a paradigm shift in the […]
Cannabis Safety

Legalizing cannabis for recreational purposes has opened doors to serious debates regarding the safety and efficacy of its use. The two most important components of marijuana- THC and CBD have been the subject of research for several decades. Studies have shown that CBD can counteract the negative effects of THC and optimize its positive therapeutic […]
I’d Like to Conduct Research on My Product. What Now?

How do you differentiate your product on the market? Is it by having a superior quality formulation compared to your competitors’? Or by having an innovative delivery system that appeals to consumers? Both will assist in having a strong intellectual property (IP) position, but the ability to make claims substantiated by scientific evidence is the […]
CBD and the Microbiome

Cannabis, commonly known as marijuana, is a botanical that has been used as alternative medicine in many cultures for several centuries. The plant produces over 421 chemical compounds, including 80 phytocannabinoids which have psychotropic tetrahydrocannabinol (THC) and non-psychoactive cannabidiol (CBD). A surprising discovery is that we have an endocannabinoid system in our bodies that is […]
Shifting Paradigms: Discussing the State of Global Health Care with Dr. Mal Evans

“We need to challenge regulatory guidelines that require natural health products to behave similarly to drugs.” Dr. Mal Evans, our CSO, recently spoke at a symposium for the Munk School of Global Affairs & Public Policy. Entitled Prospects for Japan’s G20 Osaka Summit, this conference provided a critical assessment of the agenda for the upcoming G20 event, […]
Budding Research: Conducting Clinical Cannabis Trials in Canada

It’s no secret that cannabis — also known as “marijuana,” “pot,” and in some circles, “whacky tabacky” — isn’t just for so-called “stoners.” With its powerful chemical compounds, it has been found to provide a variety of fantastic medical benefits — some of which remain to be researched. However, due to stringent restrictions on this […]
Is the Industry’s Insight into CBD Half-Baked?

“There is a knowledge gap in our current understanding of Cannabidiol.” This month, cannabis experts were able to pipe up about the challenges surrounding the industry. As part of the “early stages” of its establishment of regulatory guidelines for Cannabidiol (CBD), the US Food and Drug Administration (FDA) held its first-ever public hearing on the […]
Get the Scoop on Synbiotics

It’s no secret that dietary fibre and probiotics are both vital in the enhancement and maintenance of a healthy digestive system. However, the power they hold when united is lesser understood: together, they may greatly improve gut function. Known as synbiotics, combinations of these two components have been found to aid with gastrointestinal ailments. We’ve […]
Regulatory Developments in the Cannabiz

With the public’s interest in cannabis getting higher than ever, the industry is changing at a breakneck pace — so much so that sometimes, it can be difficult to stay abreast of its evolving rules and regulations. Thankfully, KGK has got you covered. Here’s our breakdown of recent and projected regulatory developments for this budding […]
What’s Coming Down the Pipe for Cannabis Research?

As our pursuit of cannabis knowledge continues to hasten, a large crop of innovative and interesting studies are sure to arise. But what should this novel research explore? How can we improve our investigative processes? We’ve got you covered with this comprehensive look at the future of cannabis research. Old News Recent cannabis research has […]